Date: 2016-09-28
Type of information: Collaboration agreement
Compound: bioprinting of hair
Company: Poietis (France) L'Oréal (France)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism: bioprinting
Disease:
Details:
- • On September 28, 2016, L’Oréal and Poietis announced they have signed an exclusive research partnership to develop bioprinting of hair. L'Oréal has been committed to tissue engineering for almost 30 years and holds unique knowledge and expertise in the field of hair biology. With this exclusive research partnership, L'Oréal and Poietis are giving themselves the means to pursue a new scientific challenge: bioprinting a hair follicle, the small organ that produces hair, using a bioprinter. The laser-assisted bioprinting technology developed by Poietis to produce biological tissue can position cells in 3D with extremely high cellular resolution (on the order of ten microns) and cellular viability (over 95%). This unique bioprinting technology involves successively layering micro-drops of bioinks using a quick scan by a laser beam. The living biological tissue created must then be matured for around 3 weeks before it can be used in tests. The combination of this exclusive technology with L'Oréal's unique expertise in hair biology could make it possible to create a functional follicle capable of producing hair – that is the ambition of L’Oréal and Poietis.
- Poietis and L'Oréal's multi-annual research partnership in the areas of hair biology and hair engineering should ultimately lead to new advances in hair knowledge and enable the development of exclusive efficacy testing on bioprinted hair samples.
Financial terms:
Latest news:
Is general: Yes
